301 related articles for article (PubMed ID: 36430163)
1. Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients-A Proof of Concept.
Bergantim R; Peixoto da Silva S; Polónia B; Barbosa MAG; Albergaria A; Lima J; Caires HR; Guimarães JE; Vasconcelos MH
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430163
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles Isolated from Plasma of Multiple Myeloma Patients Treated with Daratumumab Express CD38, PD-L1, and the Complement Inhibitory Proteins CD55 and CD59.
Brennan K; Iversen KF; Blanco-Fernández A; Lund T; Plesner T; Mc Gee MM
Cells; 2022 Oct; 11(21):. PubMed ID: 36359760
[TBL] [Abstract][Full Text] [Related]
3. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
[TBL] [Abstract][Full Text] [Related]
4. An update on extracellular vesicles in multiple myeloma: a focus on their role in cell-to-cell cross-talk and as potential liquid biopsy biomarkers.
De Luca L; Laurenzana I; Trino S; Lamorte D; Caivano A; Musto P
Expert Rev Mol Diagn; 2019 Mar; 19(3):249-258. PubMed ID: 30782029
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease.
Waldschmidt JM; Anand P; Knoechel B; Lohr JG
Semin Hematol; 2018 Jan; 55(1):33-37. PubMed ID: 29759150
[TBL] [Abstract][Full Text] [Related]
6. Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma.
Korthals M; Sehnke N; Kronenwett R; Schroeder T; Strapatsas T; Kobbe G; Haas R; Fenk R
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1109-15. PubMed ID: 23644045
[TBL] [Abstract][Full Text] [Related]
7. Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study.
Ferreira BV; Carneiro EA; Pestana C; Barahona F; Caetano J; Lopes R; Lúcio P; Neves M; Beck HC; Carvalho AS; Matthiesen R; Costa-Silva B; João C
Front Oncol; 2022; 12():860849. PubMed ID: 35800053
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Extracellular Vesicle and Contaminant Markers in Blood Derivatives Using Multiple Reaction Monitoring.
Newman LA; Useckaite Z; Wu T; Sorich MJ; Rowland A
Methods Mol Biol; 2023; 2628():301-320. PubMed ID: 36781794
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood.
Notarangelo M; Zucal C; Modelska A; Pesce I; Scarduelli G; Potrich C; Lunelli L; Pederzolli C; Pavan P; la Marca G; Pasini L; Ulivi P; Beltran H; Demichelis F; Provenzani A; Quattrone A; D'Agostino VG
EBioMedicine; 2019 May; 43():114-126. PubMed ID: 31047861
[TBL] [Abstract][Full Text] [Related]
10. Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and Disease.
Franco C; Ghirardello A; Bertazza L; Gasparotto M; Zanatta E; Iaccarino L; Valadi H; Doria A; Gatto M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835073
[TBL] [Abstract][Full Text] [Related]
11. Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
Harshman SW; Canella A; Ciarlariello PD; Agarwal K; Branson OE; Rocci A; Cordero H; Phelps MA; Hade EM; Dubovsky JA; Palumbo A; Rosko A; Byrd JC; Hofmeister CC; Benson DM; Paulaitis ME; Freitas MA; Pichiorri F
J Proteomics; 2016 Mar; 136():89-98. PubMed ID: 26775013
[TBL] [Abstract][Full Text] [Related]
12. Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.
Juul-Dam KL; Ommen HB; Nyvold CG; Walter C; Vålerhaugen H; Kairisto V; Abrahamsson J; Alm SJ; Jahnukainen K; Lausen B; Reinhardt D; Zeller B; von Neuhoff N; Fogelstrand L; Hasle H
Br J Haematol; 2020 Jul; 190(2):198-208. PubMed ID: 32175599
[TBL] [Abstract][Full Text] [Related]
13. Circulating extracellular vesicle-associated CD163 and CD206 in multiple myeloma.
Kvorning SL; Nielsen MC; Andersen NF; Hokland M; Andersen MN; Møller HJ
Eur J Haematol; 2020 May; 104(5):409-419. PubMed ID: 31855290
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
15. Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.
Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Yalcin B; Dee R; van Noesel MM; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
Clin Chem; 2009 Jul; 55(7):1316-26. PubMed ID: 19460840
[TBL] [Abstract][Full Text] [Related]
16. Emergence of Extracellular Vesicles as "Liquid Biopsy" for Neurological Disorders: Boom or Bust.
Kumar A; Nader MA; Deep G
Pharmacol Rev; 2024 Feb; 76(2):199-227. PubMed ID: 38351075
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma.
Wang N; Tesfaluul N; Li J; Gao X; Liu S; Yue B
Ann Hematol; 2019 Dec; 98(12):2769-2780. PubMed ID: 31748925
[TBL] [Abstract][Full Text] [Related]
19. Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia.
Muffly L; Sundaram V; Chen C; Yurkiewicz I; Kuo E; Burnash S; Spiegel JY; Arai S; Frank MJ; Johnston LJ; Lowsky R; Meyer EH; Negrin RS; Rezvani AR; Sidana S; Shiraz P; Shizuru JA; Weng WK; Liedtke M; Vempaty HT; Miklos DB
Blood Adv; 2021 Aug; 5(16):3147-3151. PubMed ID: 34424318
[TBL] [Abstract][Full Text] [Related]
20. Cancer Stem Cell Derived Extracellular Vesicles with Self-Functionalized 3D Nanosensor for Real-Time Cancer Diagnosis: Eliminating the Roadblocks in Liquid Biopsy.
Haldavnekar R; Venkatakrishnan K; Tan B
ACS Nano; 2022 Aug; 16(8):12226-12243. PubMed ID: 35968931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
